The following is a summary of “Right atrial reservoir strain as an early predictor of pulmonary hypertension development in ...

Get Instant Summarized Text (Gist) Pulmonary artery denervation (PADN) shows promise as an intervention for pulmonary hypertension, improving key hemodynamic parameters and clinical outcomes. A ...

Pulmonary artery denervation has become a promising therapeutic intervention in the management of pulmonary hypertension. While our findings suggest a substantial role for PADN in treatment ...

Original Medicare and Part C should provide a comprehensive pulmonary rehabilitation program for a person who has chronic issues with breathing. Original Medicare includes Part A, which is ...

Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected population with an elevated estimated pulmonary artery systolic pressure (ePASP) on ...

Background The vertebral artery (VA) ostium (VAO) is a common stenosis site. Most patients with VAO stenosis refractory to medical treatment are treated endovascularly using stenting. To optimally ...

Main pulmonary artery (MPA) diameter is a prognostic indicator in patients with pulmonary arterial hypertension (PAH) without congenital heart disease, according to study findings published in Chest.

There is no easy way to unclog an artery once plaque has built up. However, dietary choices, exercise, and avoiding smoking can improve cardiovascular health and stop blockages from worsening.

The investigator-led study enrolled 50 patients undergoing routine right heart catheterization (RHC), with CPS successfully measuring mean pulmonary artery pressure (mPAP) in 40 subjects.

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the ...

Semaglutide, a GLP-1 receptor agonist, improves glycaemic control and cardiovascular outcomes in patients with type 2 diabetes and those with cardiovascular disease, including peripheral artery ...